Impact BioMedical Statistics
Share Statistics
Impact BioMedical has 11.5M
shares outstanding. The number of shares has increased by null%
in one year.
| Shares Outstanding | 11.5M |
| Shares Change (YoY) | n/a |
| Shares Change (QoQ) | n/a |
| Owned by Institutions (%) | n/a |
| Shares Floating | n/a |
| Failed to Deliver (FTD) Shares | 1,562 |
| FTD / Avg. Volume | 0.02% |
Short Selling Information
| Short Interest | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Valuation Ratios
The PE ratio is -8805.66 and the forward
PE ratio is null.
Impact BioMedical's PEG ratio is
-106.29.
| PE Ratio | -8805.66 |
| Forward PE | n/a |
| PS Ratio | 86314.58 |
| Forward PS | n/a |
| PB Ratio | 23440.83 |
| P/FCF Ratio | -20869.09 |
| PEG Ratio | -106.29 |
Financial Ratio HistoryEnterprise Valuation
Currently the Enterprise Value (EV) is not available for Impact BioMedical.
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 1.6,
with a Debt / Equity ratio of 0.44.
| Current Ratio | 1.6 |
| Quick Ratio | 1.6 |
| Debt / Equity | 0.44 |
| Debt / EBITDA | -0.38 |
| Debt / FCF | -0.39 |
| Interest Coverage | 7.34 |
Financial Efficiency
Return on Equity is n/a and Return on Invested Capital is n/a.
| Return on Equity | n/a |
| Return on Assets | n/a |
| Return on Invested Capital | n/a |
| Revenue Per Employee | $535,402 |
| Profits Per Employee | $-5,248,101 |
| Employee Count | 2 |
| Asset Turnover | 0.17 |
| Inventory Turnover | n/a |
Taxes
| Income Tax | -59.8K |
| Effective Tax Rate | 0.57% |
Stock Price Statistics
The stock price has increased by -99.87% in the
last 52 weeks. The beta is 7.47, so Impact BioMedical's
price volatility has been higher than the market average.
| Beta | 7.47 |
| 52-Week Price Change | -99.87% |
| 50-Day Moving Average | 1 |
| 200-Day Moving Average | n/a |
| Relative Strength Index (RSI) | 44.34 |
| Average Volume (20 Days) | 9,564,286 |
Income Statement
In the last 12 months, Impact BioMedical had revenue of 1.07M
and earned -10.5M
in profits. Earnings per share was -0.06.
| Revenue | 1.07M |
| Gross Profit | 1.07M |
| Operating Income | 497.15K |
| Net Income | -10.5M |
| EBITDA | -4.61M |
| EBIT | n/a |
| Earnings Per Share (EPS) | -0.06 |
Full Income StatementBalance Sheet
The company has 726.05K in cash and 1.74M in
debt, giving a net cash position of -1.01M.
| Cash & Cash Equivalents | 726.05K |
| Total Debt | 1.74M |
| Net Cash | -1.01M |
| Retained Earnings | -22.74M |
| Total Assets | 5.87M |
| Working Capital | -552.12K |
Full Balance SheetCash Flow
In the last 12 months, operating cash flow was -4.33M
and capital expenditures -95.68K, giving a free cash flow of -4.43M.
| Operating Cash Flow | -4.33M |
| Capital Expenditures | -95.68K |
| Free Cash Flow | -4.43M |
| FCF Per Share | -0.02 |
Full Cash Flow StatementMargins
Gross margin is 100%, with operating and profit margins of 46.43% and -980.22%.
| Gross Margin | 100% |
| Operating Margin | 46.43% |
| Pretax Margin | -980.22% |
| Profit Margin | -980.22% |
| EBITDA Margin | -430.27% |
| EBIT Margin | 46.43% |
| FCF Margin | -413.6% |
